Benzinga's Top Upgrades

Analysts at JMP Securities upgraded Edwards Lifesciences EW from “market perform” to “outperform.” The target price for Edwards Lifesciences is set to $97. Edwards Lifesciences' shares closed at $80.71 yesterday. Nomura upgraded Marvell Technology Group MRVL from “neutral” to “buy.” The target price for Marvell Technology has been raised from $15 to $19. Marvell Technology's shares closed at $14.83 yesterday. Analysts at Baird upgraded Achillion Pharmaceuticals ACHN from “neutral” to “outperform.” The target price for Achillion Pharmaceuticals has been raised from $4 to $12. Achillion's shares closed at $7.79 yesterday. Analysts at Bank of America upgraded SanDisk SNDK from “underperform” to “buy.” SanDisk's shares closed at $97.14 yesterday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesAnalyst Ratingstop upgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!